Free Trial

Integer Holdings Corporation $ITGR Shares Bought by Tudor Investment Corp ET AL

Integer logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Tudor Investment Corp ET AL dramatically increased its reported stake in Integer, buying an additional 29,442,029 shares in the quarter to hold 29,500,000 shares (per the SEC filing).
  • Integer beat the latest quarter's expectations with $1.76 EPS (vs. $1.70 est.) and $472.06M revenue (vs. $462.73M est.), and issued FY2026 guidance of 6.29–6.78 EPS (sell-side consensus ~6.01).
  • Institutional ownership is very high at 99.29%, insiders own 2.16%, and analyst coverage is mixed — consensus rating "Hold" with an average price target of $102 and several recent target revisions.
  • Interested in Integer? Here are five stocks we like better.

Tudor Investment Corp ET AL grew its position in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 50,787.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,500,000 shares of the medical equipment provider's stock after purchasing an additional 29,442,029 shares during the quarter. Tudor Investment Corp ET AL owned approximately 84.19% of Integer worth $28,606,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Integer by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider's stock worth $2,539,000 after acquiring an additional 837 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Integer by 2,408.8% in the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider's stock valued at $14,531,000 after buying an additional 118,224 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Integer by 79,888.9% in the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider's stock valued at $850,000 after buying an additional 7,190 shares during the last quarter. United Services Automobile Association purchased a new stake in Integer in the first quarter valued at $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Integer by 4.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock valued at $12,900,000 after acquiring an additional 4,873 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, VP Tommy P. Thomas sold 825 shares of the company's stock in a transaction on Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the transaction, the vice president directly owned 4,381 shares of the company's stock, valued at $372,385. This represents a 15.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.16% of the company's stock.

Analyst Ratings Changes

ITGR has been the subject of several research reports. Truist Financial boosted their target price on Integer from $95.00 to $97.00 and gave the company a "buy" rating in a report on Friday, February 20th. Citigroup increased their price objective on Integer from $75.00 to $92.00 and gave the company a "neutral" rating in a report on Friday, February 20th. Weiss Ratings raised shares of Integer from a "sell (d+)" rating to a "hold (c-)" rating in a report on Tuesday, February 24th. Wall Street Zen cut shares of Integer from a "buy" rating to a "hold" rating in a research note on Sunday, January 25th. Finally, Raymond James Financial restated an "outperform" rating and issued a $101.00 price objective on shares of Integer in a research note on Monday, February 23rd. Four investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $102.00.

Check Out Our Latest Research Report on Integer

Integer Stock Performance

NYSE:ITGR opened at $84.49 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. The firm has a market cap of $2.91 billion, a price-to-earnings ratio of 29.44, a price-to-earnings-growth ratio of 1.44 and a beta of 0.75. The firm's fifty day moving average price is $85.55 and its 200 day moving average price is $85.37. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $127.56.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.70 by $0.06. The company had revenue of $472.06 million during the quarter, compared to analysts' expectations of $462.73 million. Integer had a net margin of 5.55% and a return on equity of 13.26%. The business's revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the business earned $1.43 EPS. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. On average, sell-side analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer Profile

(Free Report)

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

Further Reading

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines